ILK (Restricted sale due to demands of patent holder) Immunizing Peptide |
|||
| MBS427054-01mg | MyBiosource | 0.1mg | EUR 225 |
JAK2 (Restricted sale due to demands of patent holder) Immunizing Peptide |
|||
| MBS427057-01mg | MyBiosource | 0.1mg | EUR 225 |
Anti-ABCG2 / BCRP (Restricted sale due to demands of patent holder) antibody |
|||
| STJ73430 | St John's Laboratory | 100 µg | EUR 430.8 |
EPO-PEG-EPO |
|||
| abx085039-100l | Abbexa | 100 µl | EUR 275 |
EPO-PEG-EPO |
|||
| abx085039-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 427.2 |
EPO-PEG-EPO |
|||
| abx085039-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 427.2 |
EPO-PEG-EPO |
|||
| abx085039-1ml | Abbexa | 1 ml | EUR 275 |
EPO-PEG-EPO |
|||
| abx085039-200l | Abbexa | 200 µl | EUR 275 |
EPO-PEG-EPO |
|||
| abx085039-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 427.2 |
Goat anti-ABCG2 / BCRP (Restricted sale due to demands of patent holder) Antibody |
|||
| dAP-3126 | Angio Proteomie | 50ug | EUR 264.6 |
Erythropoietin (EPO) (EPO/1367) Antibody |
|||
| BNC701367-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Erythropoietin (EPO) (EPO/1367),CF770 conjugate, Concentration: 0.1mg/mL |
|||
Erythropoietin (EPO) (EPO/1367) Antibody |
|||
| BNC701367-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Erythropoietin (EPO) (EPO/1367),CF770 conjugate, Concentration: 0.1mg/mL |
|||
Erythropoietin (EPO) (EPO/1368) Antibody |
|||
| BNC701368-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Erythropoietin (EPO) (EPO/1368),CF770 conjugate, Concentration: 0.1mg/mL |
|||
Erythropoietin (EPO) (EPO/1368) Antibody |
|||
| BNC701368-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Erythropoietin (EPO) (EPO/1368),CF770 conjugate, Concentration: 0.1mg/mL |
|||
Erythropoietin (EPO) (EPO/1367) Antibody |
|||
| BNC801367-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Erythropoietin (EPO) (EPO/1367),CF680 conjugate, Concentration: 0.1mg/mL |
|||